Venous drug-eluting vs. bare-metal Stenting: An experimental animal study using frequency- domain optical coherence tomography

Hellenic Journal of Cardiology

Volumn 55, Issue 5, 2014, Pages 386-392

  Kitrou, Panagiotis M ^a   Spiliopoulos, Stavros ^a   Katsanos, Konstantinos ^a   Tsantis, Stavros ^b   Diamantopoulos, Athanasios ^a   Kallidonis, Panagiotis ^a   Kyriakopoulou, Maria ^a   Kagadis, George C ^b   Karnabatidis, Dimitrios ^a   Siablis, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Drug eluting stent; Optical coherence tomography; Rabbit; Vein

Indexed keywords

AMPICILLIN DERIVATIVE; ZOTAROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ALGORITHM; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL NEURAL NETWORK; BARE METAL STENT; BIOCOMPATIBILITY; CHEMICAL PHENOMENA; COMPARATIVE STUDY; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG ELUTING STENT; EVALUATION AND FOLLOW UP; EXPERIMENTAL ANIMAL; FEASIBILITY STUDY; FREQUENCY ANALYSIS; HYPERPLASIA; ILIAC VEIN; IMPLANTATION; MALE; NONHUMAN; RABBIT; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; WAVELET ANALYSIS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD VESSEL PROSTHESIS; DISEASE MODEL; FOLLOW UP; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASES; PROCEDURES; PROSTHESIS; RADIOGRAPHY; TIME;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY, BALLOON; ANIMALS; BLOOD VESSEL PROSTHESIS; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; ILIAC VEIN; IMMUNOSUPPRESSIVE AGENTS; MALE; PERIPHERAL VASCULAR DISEASES; PROSTHESIS DESIGN; RABBITS; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84907297786     PISSN: 11099666     EISSN: 22415955     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mansour M, Kamper L, Altenburg A, Haage P. Radiological central vein treatment in vascular access. J Vasc Access. 2008; 9: 85-101.
2. Ozyer U, Harman A, Yildirim E, Aytekin C, Karakayali F, Boyvat F. Long-term results of angioplasty and stent placement for treatment of central venous obstruction in 126 hemodialysis patients: a 10-year single-center experience. AJR Am J Roentgenol. 2009; 193: 1672-1679.
3. Katsanos K, Spiliopoulos S, Krokidis M, Karnabatidis D, Siablis D. Does below-the-knee placement of drug-eluting stents improve clinical outcomes? J Cardiovasc Surg (Torino). 2012; 53: 195-203.
4. Karnabatidis D, Spiliopoulos S, Katsanos K, Siablis D. Below- the-knee drug-eluting stents and drug-coated balloons. Expert Rev Med Devices. 2012; 9: 85-94.
5. Schwartz RS, Edelman ER, Carter A, et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation. 2002; 106: 1867-1873.
6. Karnabatidis D, Katsanos K, Diamantopoulos A, Kagadis GC, Siablis D. Transauricular arterial or venous access for cardiovascular experimental protocols in animals. J Vasc Interv Radiol. 2006; 17(11 Pt 1): 1803-1811.
7. Tsantis S, Kagadis GC, Katsanos K, Karnabatidis D, Bourantas G, Nikiforidis GC. Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography. Med Phys. 2012; 39: 503-513.
8. Kurklinsky AK, Bjarnason H, Friese JL, et al. Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience. J Vasc Interv Radiol. 2012; 23: 1009-1015.
9. Jeon UB, Chung JW, Jae HJ, et al. May-Thurner syndrome complicated by acute iliofemoral vein thrombosis: helical CT venography for evaluation of long-term stent patency and changes in the iliac vein. AJR Am J Roentgenol. 2010; 195: 751-757.
10. Bornak A, Wicky S, Ris HB, Probst H, Milesi I, Corpataux JM. Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions. Eur Radiol. 2003; 13: 950-956.
11. Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012; 19: 263-272.
12. Diskin CJ. Novel insights into the pathobiology of the vascular access - do they translate into improved care? Blood Purif. 2010; 29: 216-229.
13. Spiliopoulos S, Diamantopoulos A, Katsanos K, Ravazoula P, Karnabatidis D, Siablis D. PolarCath cryoplasty enhances smooth muscle cell apoptosis in a rabbit iliac artery model: an experimental in vivo controlled study. Cryobiology. 2011; 63: 267-272.
14. Steigerwald K, Ballke S, Quee SC, et al. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation. EuroIntervention. 2012; 8: 752-759.
15. Karnabatidis D, Katsanos K, Paraskevopoulos I, Diamantopoulos A, Spiliopoulos S, Siablis D. Frequency-domain intravascular optical coherence tomography of the femoropopliteal artery. Cardiovasc Intervent Radiol. 2011; 34: 1172-1181.
16. Kim JS, Wallace-Bradley D, Alviar CL, et al. Correlation of angiographic late loss with neointimal proliferation in stents evaluated by OCT and histology in porcine coronary arteries. JACC Cardiovasc Imaging. 2011; 4: 1002-1010.
17. John R, Adie SG, Chaney EJ, Marjanovic M, Tangella KV, Boppart SA. Three-dimensional optical coherence tomography for optical biopsy of lymph nodes and assessment of metastatic disease. Ann Surg Oncol. 2013; 20: 3685-3693.
18. Murata A, Wallace-Bradley D, Tellez A, et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging. 2010; 3: 76-84.
19. Yeh RW, Normand SL, Wolf RE, et al. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation. 2011; 124: 1557-1564.
20. Jia H, Liu H, Kong J, et al. A novel polymer-free paclitaxeleluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model. J Biomed Mater Res A. 2011; 98: 629-637.
21. Schwartz RS, Edelman ER, Carter A, et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation. 2002; 106: 1867-1873.